Vutrisiran 25mg/0.5ml Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 25mg/0.5ml
Reference Brands: Amvuttra (USA/EU)
Category: Orphan Drugs
Vutrisiran (Amvuttra) is an RNA interference (RNAi) therapeutic used to treat polyneuropathy caused by hereditary transthyretin-mediated amyloidosis (hATTR) in adults. It works by silencing the transthyretin (TTR) gene, reducing the production of abnormal TTR protein that forms amyloid deposits. The medication is administered as a subcutaneous injection (25 mg/0.5 mL) once every 3 months under medical supervision, helping to slow disease progression and improve quality of life in patients with this rare condition.
Vutrisiran — third party manufacturing & bulk supply
Vutrisiran 25mg/0.5ml is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
Indicative minimum order quantity
Vutrisiran is supplied as Injection — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Vutrisiran listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.
Request a quote for Vutrisiran →Frequently Asked Questions
Related Products
Pasireotide Diaspartate
Strength:
0.3 mg/mL, 0.6 mg/mL, 1.2 mg/mL, 10 mg, 20 mg, 30 mg
Form: Injection
Reference Brands: Signifor (USA/EU)
View Details
Sepiapterin
Strength:
1000 mg, 250 mg
Form: Tablets / oral powder
Reference Brands: Sephience (USA/EU)
View Details
Glycerol Phenylbutyrate
Strength:
1.1 g/mL
Form: Oral Solution
Reference Brands: Ravicti (USA)
View DetailsQuick Response Guaranteed | Verified Suppliers
